We are live on ! Find out more
PVLA

Palvella Therapeutics
PVLA

49 hedge funds and large institutions have $114M invested in Palvella Therapeutics in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

480% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 5

126% more capital invested

Capital invested by funds: $50.4M → $114M (+$63.5M)

81% more funds holding

Funds holding: 27 → 49 (+22)

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

0.09% more ownership

Funds ownership: 0.56% → 0.65% (+0.09%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
49
Holders Change
+22
Holders Change %
+81.48%
% of All Funds
1.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
9
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$5.75M
2
BlackRock
BlackRock
New York
+$5.1M
3
SSA
Schonfeld Strategic Advisors
New York
+$2.96M
4
State Street
State Street
Massachusetts
+$1.72M
5
Northern Trust
Northern Trust
Illinois
+$1.17M

Top Sellers

Rank Fund Capital Flow
1
LOAMU
Lombard Odier Asset Management (USA)
New York
-$4.17M
2
TCM
Tekla Capital Management
Massachusetts
-$4.03M
3
OFM
Omega Fund Management
Massachusetts
-$1.21M
4
Renaissance Technologies
Renaissance Technologies
New York
-$506K
5
DCM
DAFNA Capital Management
California
-$139K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
26
Panagora Asset Management
Massachusetts
$188K +$62.2K +213 +85%
RhumbLine Advisers
27
RhumbLine Advisers
Massachusetts
$184K +$133K +454 New
Acadian Asset Management
28
Acadian Asset Management
Massachusetts
$162K +$117K +401 New
Manulife (Manufacturers Life Insurance)
29
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$161K +$106K +364 +1,103%
State of Wisconsin Investment Board
30
State of Wisconsin Investment Board
Wisconsin
$132K +$95K +325 New
RC
31
RBF Capital
California
$127K – – –
AIG
32
American International Group
New York
$108K +$77.7K +266 New
VOYA Investment Management
33
VOYA Investment Management
Georgia
$100K +$71.9K +246 New
NFA
34
Nationwide Fund Advisors
Ohio
$98K +$70.4K +241 New
Bank of America
35
Bank of America
North Carolina
$83K -$3.8K -13 -6%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$80K +$58.2K +199 New
RJA
37
Raymond James & Associates
Florida
$76K – – –
AllianceBernstein
38
AllianceBernstein
Tennessee
$66K +$47.6K +163 New
Goldman Sachs
39
Goldman Sachs
New York
$60K +$43.5K +149 New
Parallax Volatility Advisers
40
Parallax Volatility Advisers
California
$59K +$42.4K +145 New
CS
41
Credit Suisse
Switzerland
$54K +$38.3K +131 New
SO
42
STRS Ohio
Ohio
$50K +$36.5K +125 New
Legal & General Group
43
Legal & General Group
United Kingdom
$26K +$18.7K +64 New
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$18.2K +$13.2K +45 New
AIP
45
Ameritas Investment Partners
Nebraska
$15K +$11.1K +38 New
AIM
46
Acrospire Investment Management
Illinois
$6K -$15.2K -52 -78%
Federated Hermes
47
Federated Hermes
Pennsylvania
$3K +$2.05K +7 New
GWM
48
Geneos Wealth Management
Colorado
$1K +$1.17K +4 New
DCM
49
DAFNA Capital Management
California
– -$139K -669 Closed
JP Morgan Chase
50
JP Morgan Chase
New York
– -$61K -294 Closed
1
2
3

PVLA Hedge Fund Activity: Q2 2017 in Review

49 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Palvella Therapeutics (PVLA) for Q2 2017, worth a combined $114M — up 126% from $50.4M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new PVLA positions and 5 closed out — a net gain of 24 holders — while 9 added to existing stakes and 8 trimmed.

The largest buyer was BVF Inc, adding an estimated $5.75M. The largest seller was Lombard Odier Asset Management (USA), cutting an estimated $4.17M.

  • 49 institutional investors held Palvella Therapeutics (PVLA) as of Q2 2017, up from 27 in Q1 2017.
  • Funds reported $114M of Palvella Therapeutics stock for Q2 2017, up 126% quarter-over-quarter.
  • 29 funds opened new Palvella Therapeutics positions in Q2 2017 and 5 closed out, a net change of +24 holders.
  • The largest Palvella Therapeutics buyer in Q2 2017 was BVF Inc, an estimated $5.75M added.
  • The largest Palvella Therapeutics seller in Q2 2017 was Lombard Odier Asset Management (USA), an estimated $4.17M sold.

Based on aggregated 13F filings for Q2 2017.